Account
Inquiry
Superior Peptides presents high-quality Tirzepatide (LY3298176), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. Our Superior Peptides formulation demonstrates significantly enhanced efficacy in glucose control and weight management compared to single-receptor agonists.
This Superior Peptides compound exhibits greater affinity for GIP receptors than GLP-1 receptors, with research showing superior hyperglycemia reduction compared to selective GLP-1 receptor agonists. The dual agonist mechanism of our Superior Peptides formulation mimics natural GIP action at receptor sites.
Our pharmaceutical-grade Superior Peptides Tirzepatide is supplied as a white powder with purity exceeding 99%, making it ideal for research applications in diabetes treatment development. The product maintains stability when stored under recommended conditions.
For research use only. Not for human consumption.
